Last reviewed · How we verify
NCT05240937: cancer
The Effect of Self-compassion on Breast Cancer
NA trial testing mindfulness-based self-compassion will be applied in Breast Cancer in 70 participants. Status unknown.
15 July 2022
Quick facts
| Lead sponsor | University of Beykent |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 70 |
| Start date | 15 May 2022 |
| Primary completion | 15 July 2022 |
| Estimated completion | 15 November 2022 |
Drugs / interventions tested
- mindfulness-based self-compassion will be applied
Conditions studied
- Breast Cancer — all drugs for Breast Cancer →
- Self Compassion — all drugs for Self Compassion →
Sponsor
University of Beykent
Who can join
Adults 30 to 55, female only, with Breast Cancer or Self Compassion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Most women don't want to hear the word cancer, so they feel anxious and stressed. However, "cancer" can be the beginning of learning how to fight and being hopeful. Ontological well-being is a concept that includes the life project of the individual and the meaning of life. the life of the individual; It is a project that includes the past tense, present tense and future tense components. Mindfulness-based practices are an application that examines the psychological and physiological aspects of stress and includes the concept of self-compassion. Self-compassion requires a balanced approach to one's negative emotions. When studies with breast cancer patients are examined, it is emphasized that self-compassion has an effect on concepts such as quality of life, anxiety, depression, and body image. This research was planned to determine the effectiveness of the awareness-based self-compassion program applied to patients with breast cancer on the ontological well-being of individuals.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05240937
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breast Cancer
Currently open trials in the same condition.
- NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
- NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
- NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
- NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
- NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting
Other University of Beykent trials
Trials by the same sponsor.
- NCT07457398 — Effects of Gastrocnemius Fatigue on Muscle Elasticity and Jumping · NA · completed
- NCT07069283 — The Effect of Self-Compassion Practices on Nomophobia Symptoms in Young Adults · NA · not yet recruiting
- NCT06905548 — Climate Change Awareness: a Randomized Controlled Trial · NA · not yet recruiting
- NCT07160881 — Effectiveness of CPR Pillow · NA · enrolling by invitation
- NCT06828029 — Problem-Solving Approach Training on Professional Readiness Perception · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05240937 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Beykent
- Last refreshed: 20 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05240937.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing